Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of RAD001monotherapy in Patients With Unresectable Pheochromocytoma or Extra-adrenal Paraganglioma or Non-functioning Carcinoid

NCT01152827 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01152827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01152827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of RAD001monotherapy in Patients With Unresectable Pheochromocytoma or Extra-adrenal Paraganglioma or Non-functioning Carcinoid
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2011
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extra-adrenal paraganglioma, non-functioning carcinoid, pheochromocytoma